Answer
Cimzia (certolizumab pegol) should not be used in children and adolescents under 18 because its safety and efficacy have not been established in this age group.
Sources for this answer
- Cimzia 200 mg solution for injection in pre-filled syringeUCB Pharma Limited · emc · SmPC §4.2 Posology and method of administration · Version 34Document updated
Sources checked